Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study

por Chen, Yongbiao, Hong, Hanyin, Fang, Wenzheng, Zhang, Xia, Luo, Huachun, Chen, Zhijian, Yu, Jianda, Fan, Weiqiang, Chi, Xiaobin, Peng, Yonghai
Publicado 2023

Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study

por Wang, Xinpeng, Cai, Lvjuan, Wu, Mengjing, Li, Guo, Zhu, Yunyun, Lin, Xinyue, Yan, Xue, Mo, Peng, Luo, Huachun, Fu, Zhichao
Publicado 2022